Welcome to the Oncology Network for Excellence. We are again speaking with Dr. John Eckardt on novel targeted agents in soft tissue sarcoma. Dr. Eckardt, in recent years, several previously unmet needs have been fulfilled as new targeted agents have emerged. Still today, one area of unmet need is sarcoma. Can you tell us what progress has been made in this area recently?
